Literature DB >> 20570280

Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.

A A F Santos1, J T Oliveira, C C C Lopes, I F Amorim, C M F B Vicente, F R M Gärtner, A J F Matos.   

Abstract

The histopathological and clinical aspects of canine mammary tumours (CMTs) have been widely studied, but the variation in the biological behaviour of these neoplasms hampers the identification of prognostic factors. Sustained angiogenesis has been suggested to be one of the most important factors underlying tumour growth and invasion. This process involves the action of several growth factors including vascular endothelial growth factor (VEGF). The present study characterizes the relationship between immunohistochemical expression of VEGF and gross (e.g. size and tissue fixation) and microscopical (e.g. type, growth, necrosis, lymphoid infiltration, lymph node metastasis, histological grade and proliferation index) features of CMTs. Forty-eight benign and 64 malignant CMTs were evaluated. Statistical analysis failed to show a significant relationship between VEGF expression and the pathological features, suggesting that VEGF expression occurs in both benign and malignant tumours and is independent of histological type, proliferation, tissue invasion or local metastatic capacity.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570280     DOI: 10.1016/j.jcpa.2010.04.006

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  6 in total

1.  Tarantula cubensis extract alters the degree of apoptosis and mitosis in canine mammary adenocarcinomas.

Authors:  Nilgun Gultiken; Tolga Guvenc; Duygu Kaya; Ali Reha Agaoglu; Serhan Serhat Ay; Ibrahim Kucukaslan; Birten Emre; Murat Findik; Sabine Schäfer-Somi; Selim Aslan
Journal:  J Vet Sci       Date:  2014-12-24       Impact factor: 1.672

Review 2.  Angiogenesis in spontaneous tumors and implications for comparative tumor biology.

Authors:  C Benazzi; A Al-Dissi; C H Chau; W D Figg; G Sarli; J T de Oliveira; F Gärtner
Journal:  ScientificWorldJournal       Date:  2014-01-19

3.  Immunohistochemical expression of potential therapeutic targets in canine thyroid carcinoma.

Authors:  M Campos; R Ducatelle; H S Kooistra; G Rutteman; L Duchateau; I Polis; S Daminet
Journal:  J Vet Intern Med       Date:  2014-02-24       Impact factor: 3.333

Review 4.  Current biomarkers of canine mammary tumors.

Authors:  Ilona Kaszak; Anna Ruszczak; Szymon Kanafa; Kamil Kacprzak; Magdalena Król; Piotr Jurka
Journal:  Acta Vet Scand       Date:  2018-10-29       Impact factor: 1.695

Review 5.  Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors.

Authors:  Enni Markkanen
Journal:  Front Cell Dev Biol       Date:  2019-12-17

6.  Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study.

Authors:  Andreia A Santos; Célia C Lopes; Jorge R Ribeiro; Liliana R Martins; Joana C Santos; Irina F Amorim; Fátima Gärtner; Augusto J Matos
Journal:  BMC Vet Res       Date:  2013-01-04       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.